CGRYX
Price
$35.38
Change
-$0.09 (-0.25%)
Updated
Sep 8 closing price
Net Assets
772.15M
VIVAX
Price
$71.08
Change
-$0.13 (-0.18%)
Updated
Sep 8 closing price
Net Assets
202.84B
Interact to see
Advertisement

CGRYX vs VIVAX

Header iconCGRYX vs VIVAX Comparison
Open Charts CGRYX vs VIVAXBanner chart's image
Invesco Comstock Select Y
Price$35.38
Change-$0.09 (-0.25%)
VolumeN/A
Net Assets772.15M
Vanguard Value Index I
Price$71.08
Change-$0.13 (-0.18%)
VolumeN/A
Net Assets202.84B
CGRYX vs VIVAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
CGRYX vs. VIVAX commentary
Sep 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGRYX is a StrongBuy and VIVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 203B vs. CGRYX (772M). VIVAX pays higher dividends than CGRYX: VIVAX (1.99) vs CGRYX (1.68). CGRYX was incepted earlier than VIVAX: CGRYX (29 years) vs VIVAX (33 years). CGRYX (0.69) is less costly to investors than VIVAX (0.17). CGRYX is a more actively managed with annual turnover of: 70.00 vs. VIVAX (9.00). CGRYX has a lower initial minimum investment than VIVAX: CGRYX (1000) vs VIVAX (3000). VIVAX annual gain was more profitable for investors over the last year : 7.74 vs. CGRYX (-1.65). VIVAX return over 5 years is better than : 70.18 vs. CGRYX (57.14).
CGRYXVIVAXCGRYX / VIVAX
Total Expense Ratio0.680.17400%
Annual Report Gross Expense Ratio0.690.17406%
Fund Existence29 years33 years-
Gain YTD9.9167.845126%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets772M203B0%
Annual Yield % from dividends1.681.9984%
Returns for 1 year-1.657.74-21%
Returns for 3 years11.1736.6330%
Returns for 5 years57.1470.1881%
Returns for 10 years32.75131.6425%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CGON33.072.13
+6.88%
CG Oncology
MAS76.072.09
+2.83%
Masco Corp
ALZN2.320.05
+2.20%
Alzamend Neuro Inc.
FGMC9.990.01
+0.05%
FG Merger II Corp
HONE12.97-0.03
-0.23%
HarborOne Bancorp